Guardant raises 2026 guidance as Shield tests double to 66k in Q2; Reveal volume accelerates past 100% growth

Guardant Health/Shield

In Q2 2026 earnings, Guardant reported Shield volumes reached 66,000 tests (doubling from 16,000 in Q2 2025) with $52.9M revenue. The company raised full-year 2026 guidance to $1.34-1.36B total revenue (36-38% growth) and $218-230M in Shield revenue. Reveal test volume is accelerating to >100% year-over-year growth.